H.C. Wainwright says SEC plan to dismiss suit lifts ‘major overhang’ on Coinbase
H.C. Wainwright analyst Mike Colonnese notes that Coinbase (COIN) announced that the Securities and Exchange Commission has agreed to dismiss ...
H.C. Wainwright Sticks to Its Hold Rating for Biotricity (BTCY)
H.C. Wainwright analyst Kevin Dede maintained a Hold rating on Biotricity (BTCY – Research Report) today. The company’s shares closed yesterday ...
What is HC Wainwright’s Forecast for Realbotix Q2 Earnings?
Equities research analysts at HC Wainwright issued their Q2 2025 earnings estimates for shares of Realbotix in a research report issued to clients and investors on Wednesday, February 19th. HC ...
What is HC Wainwright’s Forecast for OTLK Q1 Earnings?
HC Wainwright issued their Q1 2026 EPS estimates for Outlook Therapeutics in a note issued to investors on Tuesday, February 18th. HC Wainwright analyst D. Tsao anticipates that the company will post ...
Cleanspark Unusual Options Activity
Looking at options history for Cleanspark CLSK we detected 29 trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish ...
3SWTX : What the Options Market Tells Us About SpringWorks Therapeutics
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $60.0 for SpringWorks Therapeutics, spanning the last ...
Balchem projects strong 2025 growth amid new product launches and robust segment performance
Discover Balchem's record-breaking Q4 2024 performance with $240M in sales and innovation-driven growth in nutrition segments.